Getting into the brain: liposome-based strategies for effective drug delivery across the blood–brain barrier

References

• EhrlichPDas Sauerstoff-Bedürfnis des Organismus: Eine Farbenanalytische Studie [The oxygen demand of the organism: a color analysis study]BerlinHirschwald1885
   Google Scholar
• GoldmannEEVitalfarbung am Zentralnervensystem: Beitrag zur Physio-Pathologie des Plexus Chorioideus und der Hirnhäute [Vital staining of the central nervous system: contribution to the physiopathology of the plexus choroid and the brain membranes]BerlinKöniglich Akademie der Wissenschaften1913 German
   Google Scholar
• LewandowskyMZur lehre der cerebrospinal flüssigkeit [For the teaching of cerebrospinal fluid]Z Klin Med190040480494 German
   Google Scholar
• ReeseTSKarnovskyMJFine structural localization of a blood-brain barrier to exogenous peroxidaseJ Cell Biol1967342072176033532
   PubMed Web of Science ®Google Scholar
• HawkinsBTDavisTPThe blood-brain barrier/neurovascular unit in health and diseasePharmacol Rev20055717318515914466
   PubMed Web of Science ®Google Scholar
• PardridgeWMBlood-brain barrier deliveryDrug Discov Today200712546117198973
   PubMed Web of Science ®Google Scholar
• AbbottNJRönnbäckLHanssonEAstrocyte-endothelial interactions at the blood-brain barrierNat Rev Neurosci20067415316371949
   PubMed Web of Science ®Google Scholar
• BallabhPBraunANedergaardMThe blood-brain barrier – an overview: structure, regulation, and clinical implicationsNeurobiol Dis20041611315207256
   PubMed Web of Science ®Google Scholar
• AbbottNJPatabendigeAADolmanDEYusofSRBegleyDJStructure and function of the blood-brain barrierNeurobiol Dis201037132519664713
   PubMed Web of Science ®Google Scholar
• VorbrodtAWUltracytochemical characterization of anionic sites in the wall of brain capillariesJ Neurocytol1989183593682746307
   PubMedGoogle Scholar
• ScherrmannJMDrug delivery to brain via the blood-brain barrierVascul Pharmacol20023834935412529929
   PubMed Web of Science ®Google Scholar
• PoduriAEvronyGDCaiXWalshCASomatic mutation, genomic variation, and neurological diseaseScience2013341123775823828942
   PubMed Web of Science ®Google Scholar
• QureshiIAMehlerMFEpigenetic mechanisms underlying the pathogenesis of neurogenetic diseasesNeurotherapeutics20141170872025261112
   PubMedGoogle Scholar
• LesniakMSBremHTargeted therapy for brain tumoursNat Rev Drug Discov2004349950815173839
   PubMed Web of Science ®Google Scholar
• StenehjemDDHartzAMBauerBAndersonGWNovel and emerging strategies in drug delivery for overcoming the blood-brain barrierFuture Med Chem200911623164121425983
   PubMed Web of Science ®Google Scholar
• PavanBDalpiazACilibertiNBiondiCManfrediniSVertuaniSProgress in drug delivery to the central nervous system by the prodrug approachMolecules2008131035106518560328
   PubMed Web of Science ®Google Scholar
• GabathulerRApproaches to transport therapeutic drugs across the blood-brain barrier to treat brain diseasesNeurobiol Dis201037485719664710
   PubMed Web of Science ®Google Scholar
• PardridgeWMDrug delivery to the brainJ Cereb Blood Flow Metab1997177137319270488
   PubMed Web of Science ®Google Scholar
• BanksWAFrom blood-brain barrier to blood-brain interface: new opportunities for CNS drug deliveryNat Rev Drug Discov20161527529226794270
   PubMed Web of Science ®Google Scholar
• FlemingABSaltzmanWMPharmacokinetics of the carmustine implantClin Pharmacokinet20024140341912074689
   PubMed Web of Science ®Google Scholar
• BaruaNUGillSSLoveSConvection-Enhanced drug delivery to the brain: therapeutic potential and neuropathological considerationsBrain Pathol20142411712723944716
   PubMed Web of Science ®Google Scholar
• AryalMArvanitisCDAlexanderPMMcDannoldNUltrasound-mediated blood-brain barrier disruption for targeted drug delivery in the central nervous systemAdv Drug Deliv Rev2014729410924462453
   PubMed Web of Science ®Google Scholar
• KingABreaking through the barrierChem World201183639
   Google Scholar
• BertrandYCurrieJCPoirierJInfluence of glioma tumour microenvironment on the transport of ANG1005 via low-density lipoprotein receptor-related protein 1Br J Cancer20111051697170722027709
   PubMed Web of Science ®Google Scholar
• SpencerBJVermaIMTargeted delivery of proteins across the blood-brain barrierProc Natl Acad Sci U S A20071047594759917463083
   PubMed Web of Science ®Google Scholar
• ChéCYangGThiotCNew Angiopep-modified doxorubicin (ANG1007) and etoposide (ANG1009) chemotherapeutics with increased brain penetrationJ Med Chem2010532814282420210346
   PubMed Web of Science ®Google Scholar
• VlieghePKhrestchatiskyMMedicinal chemistry based approaches and nanotechnology-based systems to improve CNS drug targeting and deliveryMed Res Rev20133345751622434495
   PubMed Web of Science ®Google Scholar
• BhaskarSTianFStoegerTMultifunctional nanocarriers for diagnostics, drug delivery and targeted treatment across blood-brain barrier: perspectives on tracking and neuroimagingPart Fibre Toxicol20107320199661
   PubMed Web of Science ®Google Scholar
• LaiFFaddaAMSinicoCLiposomes for brain deliveryExpert Opin Drug Deliv2013101003102223373728
   PubMed Web of Science ®Google Scholar
• Ramos-CabrerPCamposFLiposomes and nanotechnology in drug development: focus on neurological targetsInt J Nanomedicine2013895196023486739
   PubMed Web of Science ®Google Scholar
• KreuterJDrug delivery to the central nervous system by polymeric nanoparticles: What do we know?Adv Drug Deliv Rev20147121423981489
   PubMed Web of Science ®Google Scholar
• PatelTZhouJPiepmeierJMSaltzmanWMPolymeric nanoparticles for drug delivery to the central nervous systemAdv Drug Deliv Rev20126470170522210134
   PubMed Web of Science ®Google Scholar
• RenJShenSWangDThe targeted delivery of anticancer drugs to brain glioma by PEGylated oxidized multi-walled carbon nanotubes modified with angiopep-2Biomaterials2012333324333322281423
   PubMed Web of Science ®Google Scholar
• Al-JamalKTGherardiniLBardiGFunctional motor recovery from brain ischemic insult by carbon nanotube-mediated siRNA silencingProc Natl Acad Sci U S A2011108109521095721690348
   PubMed Web of Science ®Google Scholar
• TsengYKaoYLiaoJChenWLiuSBiodegradable drug-eluting poly(lactic-co-glycol acid) nanofibers for the sustainable delivery of vancomycin to brain tissue: in vitro and in vivo studiesACS Chem Neurosci201341314132123815098
   PubMed Web of Science ®Google Scholar
• XieJWangCHElectrospun micro- and nanofibers for sustained delivery of paclitaxel to treat C6 Glioma in vitroPharm Res2006231817182616841195
   PubMed Web of Science ®Google Scholar
• SomaniSDufèsCApplications of dendrimers for brain delivery and cancer therapyNanomedicine (Lond)201492403241425413857
   PubMed Web of Science ®Google Scholar
• Pérez-MartínezFCOcañaAVPérez-CarriónMDCeñaVDendrimers as vectors for genetic material delivery to the nervous systemCurr Med Chem2012195101510822963638
   PubMed Web of Science ®Google Scholar
• MorshedRAChengYAuffingerBWegscheidMLLesniakMSThe potential of polymeric micelles in the context of glioblastoma therapyFront Pharmacol2013415724416018
   PubMed Web of Science ®Google Scholar
• SharmaHSMenonPKLafuenteJVThe role of functionalized magnetic iron oxide nanoparticles in the central nervous system injury and repair: new potentials for neuroprotection with Cerebrolysin therapyJ Nanosci Nanotechnol20141457759524730284
   PubMed Web of Science ®Google Scholar
• LiWChenXGold nanoparticles for photoacoustic imagingNanomedicine (Lond)20151029932025600972
   PubMed Web of Science ®Google Scholar
• World Health OrganizationNeurological Disorders: Public Health ChallengesGenevaWHO2006
   Google Scholar
• MicheliMRBovaRMaginiAPolidoroMEmilianiCLipid-based nanocarriers for CNS-targeted drug deliveryRecent Pat CNS Drug Discov20127718622283231
   PubMedGoogle Scholar
• SchnyderAHuwylerJDrug transport to brain with targeted liposomesNeuroRX200529910715717061
   PubMedGoogle Scholar
• JohnsenKBMoosTRevisiting nanoparticle technology for blood-brain barrier transport: unfolding at the endothelial gate improves the fate of transferrin receptor-targeted liposomesJ Control Release2016222324626658072
   PubMed Web of Science ®Google Scholar
• NobleGTStefanickJFAshleyJDKiziltepeTBilgicerBLigand-targeted liposome design: challenges and fundamental considerationsTrends Biotechnol201432324524210498
   PubMed Web of Science ®Google Scholar
• TorchilinVPRecent advances with liposomes as pharmaceutical carriersNat Rev Drug Discov2005414516015688077
   PubMed Web of Science ®Google Scholar
• LoyseAThangarajHEasterbrookPCryptococcal meningitis: improving access to essential antifungal medicines in resource-poor countriesLancet Infect Dis20131362963723735626
   PubMed Web of Science ®Google Scholar
• RobinsonRFNahataMCA comparative review of conventional and lipid formulations of amphotericin BJ Clin Pharm Ther19992424925710475983
   PubMed Web of Science ®Google Scholar
• LippensRJLiposomal daunorubicin (DaunoXome) in children with recurrent or progressive brain tumorsPediatr Hematol199916131139
   PubMed Web of Science ®Google Scholar
• BeneschMUrbanCLiposomal cytarabine for leukemic and lymphomatous meningitis: recent developmentsExpert Opin Pharmacother2008930130918201152
   PubMed Web of Science ®Google Scholar
• AnandaSNowakAKCherLPhase 2 trial of temozolomide and PEGylated liposomal doxorubicin in the treatment of patients with glioblastoma multiforme following concurrent radiotherapy and chemotherapyJ Clin Neurosci2011181444144821813279
   PubMed Web of Science ®Google Scholar
• BeierCPSchmidCGorliaTRNOP-09: PEGylated liposomal doxorubicine and prolonged temozolomide in addition to radiotherapy in newly diagnosed glioblastoma – a phase II studyBMC Cancer2009930819725960
   PubMed Web of Science ®Google Scholar
• HauPFabelKBaumgartUPEGylated liposomal doxorubicin-efficacy in patients with recurrent high-grade gliomaCancer20041001199120715022287
   PubMed Web of Science ®Google Scholar
• ChuaSLRosenthalMAWongSSPhase 2 study of temozolomide and Caelyx in patients with recurrent glioblastoma multiformeNeuro Oncol20046384314769139
   PubMed Web of Science ®Google Scholar
• WagnerSPetersOFelsCPEGylated-liposomal doxorubicin and oral topotecan in eight children with relapsed high-grade malignant brain tumorsJ Neurooncol20088617518117641821
   PubMed Web of Science ®Google Scholar
• MarinaNMCochraneDHarneyEDose escalation and pharmacokinetics of PEGylated liposomal doxorubicin (Doxil) in children with solid tumors: a pediatric oncology group studyClin Cancer Res2002841341811839657
   PubMed Web of Science ®Google Scholar
• Di LeggeATrivellizziINMoruzziMCPesceAScambiaGLorussoDPhase 2 trial of nonPEGylated doxorubicin (Myocet) as second-line treatment in advanced or recurrent endometrial cancerInt J Gynecol Cancer2011211446145122027749
   PubMed Web of Science ®Google Scholar
• VieiraDBGamarraLFAdvances in the use of nanocarriers for cancer diagnosis and treatmentEinstein (Sao Paulo)2016149910327074238
   PubMed Web of Science ®Google Scholar
• JoshiSSingh-MoonRPEllisJACerebral hypoperfusion-assisted intra-arterial deposition of liposomes in normal and glioma-bearing ratsNeurosurgery2015769210025525695
   PubMed Web of Science ®Google Scholar
• JoshiSSingh-MoonRWangMCationic surface charge enhances early regional deposition of liposomes after intracarotid injectionJ Neurooncol201412048949725195130
   PubMed Web of Science ®Google Scholar
• JoshiSSingh-MoonRPWangMTransient cerebral hypoperfusion assisted intraarterial cationic liposome delivery to brain tissueJ Neurooncol2014118738224664370
   PubMed Web of Science ®Google Scholar
• HuwylerJWuDPardridgeWMBrain drug delivery of small molecules using immunoliposomesProc Natl Acad Sci U S A19969314164141698943078
   PubMed Web of Science ®Google Scholar
• McNeeleyKMAnnapragadaABellamkondaRVDecreased circulation time offsets increased efficacy of PEGylated nanocarriers targeting folate receptors of gliomaNanotechnology200718385101
   Web of Science ®Google Scholar
• McNeeleyKMKarathanasisEAnnapragadaAVBellamkondaRVMasking and triggered unmasking of targeting ligands on nanocarriers to improve drug delivery to brain tumorsBiomaterials2009303986399519427688
   PubMed Web of Science ®Google Scholar
• DingHSagarVAgudeloMEnhanced blood-brain barrier transmigration using a novel transferrin embedded fluorescent magnetoliposome nanoformulationNanotechnology20142505510124406534
   PubMed Web of Science ®Google Scholar
• NairMPNSaiyedSMinventorsThe Florida International University Board Of Trustees, assigneeMagnetic nanodelivery of therapeutic agents across the blood brain barrierUnited States patent US20110213193 A1201191
   Google Scholar
• GuoHChenWSunXLiuYNLiJWangJTheranostic magnetoliposomes coated by carboxymethyl dextran with controlled release by low-frequency alternating magnetic fieldCarbohydr Polym201511820921725542126
   PubMed Web of Science ®Google Scholar
• ShazeebMSFeulaGBogdanovALiposome-encapsulated superoxide dismutase mimetic: theranostic potential of an MR detectable and neuroprotective agentContrast Media Mol Imaging2014922122824700749
   PubMed Web of Science ®Google Scholar
• KarmaliPPChaudhuriACationic liposomes as non-viral carriers of gene medicines: resolved issues, open questions, and future promisesMed Res Rev20072769672217022036
   PubMed Web of Science ®Google Scholar
• DassCRChoongPFTargeting of small molecule anticancer drugs to the tumour and its vasculature using cationic liposomes: lessons from gene therapyCancer Cell Int200661716792817
   PubMed Web of Science ®Google Scholar
• ChenWLiHLiuZYuanWLipopolyplex for therapeutic gene delivery and its application for the treatment of Parkinson’s diseaseFront Aging Neurosci201686827092073
   PubMed Web of Science ®Google Scholar
• LajoieJMShustaEVTargeting receptor-mediated transport for delivery of biologics across the blood-brain barrierAnnu Rev Pharmacol Toxicol20155561363125340933
   PubMed Web of Science ®Google Scholar
• McConnellEMHolahanMRDeRosaMCAptamers as promising molecular recognition elements for diagnostics and therapeutics in the central nervous systemNucleic Acid Ther20142438840425296265
   PubMedGoogle Scholar
• KelkarSSReinekeTMTheranostics: combining imaging and therapyBioconjug Chem2011221879190321830812
   PubMed Web of Science ®Google Scholar
• WenCJZhangLWAl-SuwayehSAYenTCFangJYTheranostic liposomes loaded with quantum dots and apomorphine for brain targeting and bioimagingInt J Nanomedicine201271599161122619515
   PubMed Web of Science ®Google Scholar
• LernerENvan ZantenEHStewartGREnhanced delivery of octreotide to the brain via transnasal iontophoretic administrationJ Drug Target20041227328015512778
   PubMed Web of Science ®Google Scholar
• MistryAStolnikSIllumLNanoparticles for direct nose-to-brain delivery of drugsInt J Pharm200937914615719555750
   PubMed Web of Science ®Google Scholar
• WuHHuKJiangXFrom nose to brain: understanding transport capacity and transport rate of drugsExpert Opin Drug Deliv200851159116818817519
   PubMed Web of Science ®Google Scholar
• ArumugamKSubramanianGSMallayasamySRAverineniRKReddyMSUdupaNA study of rivastigmine liposomes for delivery into the brain through intranasal routeActa Pharm20085828729719103565
   PubMed Web of Science ®Google Scholar
• MiglioreMMVyasTKCampbellRBAmijiMMWaszczakBLBrain delivery of proteins by the intranasal route of administration: a comparison of cationic liposomes versus aqueous solution formulationsJ Pharm Sci2010991745176119774660
   PubMed Web of Science ®Google Scholar
• RossCAPoirierMAProtein aggregation and neurodegenerative diseaseNat Med200410S10S1715272267
   PubMed Web of Science ®Google Scholar
• RotmanMWellingMMBunschotenAEnhanced glutathione PEGylated liposomal brain delivery of an anti-amyloid single domain antibody fragment in a mouse model for Alzheimer’s diseaseJ Control Release2015203405025668771
   PubMed Web of Science ®Google Scholar
• BalducciCManciniSMinnitiSMultifunctional liposomes reduce brain β-amyloid burden and ameliorate memory impairment in Alzheimer’s disease mouse modelsJ Neurosci201434140221403125319699
   PubMed Web of Science ®Google Scholar
• BanaLMinnitiSSalvatiELiposomes bi-functionalized with phosphatidic acid and an ApoE-derived peptide affect Aβ aggregation features and cross the blood-brain-barrier: implications for therapy of Alzheimer diseaseNanomedicine2014101583159024333591
   PubMed Web of Science ®Google Scholar
• MutluNBDeğimZYılmazSEşsizDNacarANew perspective for the treatment of Alzheimer diseases: liposomal rivastigmine formulationsDrug Dev Ind Pharm20113777578921231901
   PubMed Web of Science ®Google Scholar
• TanifumEADasguptaISrivastavaMIntravenous delivery of targeted liposomes to amyloid-β pathology in APP/PSEN1 transgenic micePLoS One20127e4851523119043
   PubMed Web of Science ®Google Scholar
• ChenZLHuangMWangXRTransferrin-modified liposome promotes α-mangostin to penetrate the blood-brain barrierNanomedicine20161242143026711963
   PubMed Web of Science ®Google Scholar
• Ordóñez-GutiérrezLReFBereczkiERepeated intraperitoneal injections of liposomes containing phosphatidic acid and cardiolipin reduce amyloid-β levels in APP/PS1 transgenic miceNanomedicine20151142143025461285
   PubMed Web of Science ®Google Scholar
• YangZZZhangYQWangZZWuKLouJNQiXREnhanced brain distribution and pharmacodynamics of rivastigmine by liposomes following intranasal administrationInt J Pharm201345234435423680731
   PubMed Web of Science ®Google Scholar
• IsmailMFElmeshadANSalemNAPotential therapeutic effect of nanobased formulation of rivastigmine on rat model of Alzheimer’s diseaseInt J Nanomedicine2013839340623378761
   PubMed Web of Science ®Google Scholar
• LiWZhouYZhaoNHaoBWangXKongPPharmacokinetic behavior and efficiency of acetylcholinesterase inhibition in rat brain after intranasal administration of galanthamine hydrobromide loaded flexible liposomesEnviron Toxicol Pharmacol20123427227922613079
   PubMed Web of Science ®Google Scholar
• Tong-UnTMuchimapuraSPhachonpaiWWattanathornJNasal administration of quercetin liposomes modulate cognitive impairment and inhibit acetylcholinesterase activity in hippocampusAm J Neurosci201012127
   Google Scholar
• PhachonpaiWWattanathornJMuchimapuraSPreechagoonDNeuroprotective effect of quercetin encapsulated liposomes: a novel therapeutic strategy against Alzheimer’s diseaseAm J Appl Sci20107480485
   Google Scholar
• WattanathoJPhachonpaiWPripremASuthiparinSIntranasal administration of quercetin liposome decreases anxiety-like behavior and increases spatial memoryAm J Agric Biol Sci200723135
   Google Scholar
• XiangYWuQLiangLChlorotoxin-modified stealth liposomes encapsulating levodopa for the targeting delivery against the Parkinson’s disease in the MPTP-induced mice modelJ Drug Target201220677522149216
   PubMed Web of Science ®Google Scholar
• KucherianuVGIurasovVVKryzhanovskiĭGNThe effect of liposomal form of L-Dopa on the development of parkinsonian syndrome in miceBiull Eksp Biol Med19971232933 Russian9213451
   PubMedGoogle Scholar
• YurasovVVKucheryanuVGKudrinVSEffect of long-term parenteral administration of empty and L-Dopa-loaded liposomes on the turnover of dopamine and its metabolites in the striatum of mice with experimental Parkinson’s syndromeBull Exp Biol Med1997123126129
   Google Scholar
• YurasovVVPodgornyiGNKucheryanuVGEffects of L-Dopa-carrying liposomes on striatal concentration of dopamine and its metabolites and phospholipid metabolism in experimental Parkinson’s syndromeBull Exp Biol Med199612211801183
   Google Scholar
• MiglioreMMOrtizRDyeSCampbellRBAmijiMMWaszczakBLNeurotrophic and neuroprotective efficacy of intranasal GDNF in a rat model of Parkinson’s diseaseNeuroscience2014274112324845869
   PubMed Web of Science ®Google Scholar
• XiaCFBoadoRJZhangYChuCPardridgeWMIntravenous glial-derived neurotrophic factor gene therapy of experimental Parkinson’s disease with Trojan horse liposomes and a tyrosine hydroxylase promoterJ Gene Med20081030631518085726
   PubMed Web of Science ®Google Scholar
• Di StefanoASozioPIannitelliAMarianecciCSantucciECarafaMMaleic- and fumaric-diamides of (O,O-diacetyl)-L-Dopa-methylester as anti-Parkinson prodrugs in liposomal formulationJ Drug Target20061465266117090401
   PubMed Web of Science ®Google Scholar
• Di StefanoACarafaMSozioPEvaluation of rat striatal L-dopa and DA concentration after intraperitoneal administration of L-dopa prodrugs in liposomal formulationsJ Control Release20049929330015380638
   PubMed Web of Science ®Google Scholar
• KrsticDKnueselIDeciphering the mechanism underlying late-onset Alzheimer diseaseNat Rev Neurol20129253423183882
   PubMed Web of Science ®Google Scholar
• LiptonSAGuZNakamuraTInflammatory mediators leading to protein misfolding and uncompetitive/fast off-rate drug therapy for neurodegenerative disordersInt Rev Neurobiol20078212717678953
   PubMed Web of Science ®Google Scholar
• MoreiraPISiedlakSLAlievGOxidative stress mechanisms and potential therapeutics in Alzheimer diseaseJ Neural Transm (Vienna)200511292193215583960
   PubMedGoogle Scholar
• OddoSLaFerlaFMThe role of nicotinic acetylcholine receptors in Alzheimer’s diseaseJ Physiol Paris20069917217916448808
   PubMed Web of Science ®Google Scholar
• WenkGLRosiSMcGannKHauss-WegrzyniakBA nitric oxide-donating flurbiprofen derivative reduces neuroinflammation without interacting with galantamine in the ratEur J Pharmacol200245331932412398920
   PubMed Web of Science ®Google Scholar
• KanMJLeeJEWilsonJGArginine deprivation and immune suppression in a mouse model of Alzheimer’s diseaseJ Neurosci2015355969598225878270
   PubMedGoogle Scholar
• HansenRAGartlehnerGWebbAPMorganLCMooreCGJonasDEEfficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alzheimer’s disease: a systematic review and meta-analysisClin Interv Aging2008321122518686744
   PubMed Web of Science ®Google Scholar
• ConfaloniATostoGTataAPromising therapies for Alzheimer’s diseaseCurr Pharm Des2016222050205626876218
   PubMedGoogle Scholar
• ZhengXShaoXZhangCIntranasal H102 peptide-loaded liposomes for brain delivery to treat Alzheimer’s diseasePharm Res2015323837384926113236
   PubMed Web of Science ®Google Scholar
• LazarANMourtasSYoussefICurcumin-conjugated nanoliposomes with high affinity for Aβ deposits: possible applications to Alzheimer diseaseNanomedicine2013971272123220328
   PubMed Web of Science ®Google Scholar
• TheunisCCrespo-BielNGafnerVEfficacy and safety of a liposome-based vaccine against protein tau, assessed in tau.P301L mice that model tauopathyPLoS One20138e7230123977276
   PubMed Web of Science ®Google Scholar
• CarreraIEtcheverríaILiYImmunocytochemical characterization of Alzheimer disease hallmarks in APP/PS1 transgenic mice treated with a new anti-amyloid-β vaccineBiomed Res Int2013201370914524089686
   PubMedGoogle Scholar
• NicolauCGreferathRBalabanTSLazarteJEHopkinsRJA liposome-based therapeutic vaccine against β-amyloid plaques on the pancreas of transgenic NORBA miceProc Natl Acad Sci U S A2002992332233711842183
   PubMed Web of Science ®Google Scholar
• LeeHJBaeEJLeeSJExtracellular α-synuclein: a novel and crucial factor in Lewy body diseasesNat Rev Neurol201410929824468877
   PubMed Web of Science ®Google Scholar
• DauerWPrzedborskiSParkinson’s disease: mechanisms and modelsNeuron20033988990912971891
   PubMed Web of Science ®Google Scholar
• NagatsuTSawadaML-dopa therapy for Parkinson’s disease: past, present, and futureParkinsonism Relat Disord200915S3S819131039
   PubMed Web of Science ®Google Scholar
• BlackKJCarlJLHartleinJMWarrenSLHersheyTPerlmutterJSRapid intravenous loading of levodopa for human research: clinical resultsJ Neurosci Methods2003127192912865145
   PubMed Web of Science ®Google Scholar
• LinLFDohertyDHLileJDBekteshSCollinsFGDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neuronsScience1993260113011328493557
   PubMed Web of Science ®Google Scholar
• GashDMZhangZGerhardtGNeuroprotective and neurorestorative properties of GDNFAnn Neurol199844S121S1259749583
   PubMed Web of Science ®Google Scholar
• GrondinRGashDMGlial cell line-derived neurotrophic factor (GDNF): a drug candidate for the treatment of Parkinson’s diseaseJ Neurol1998245P35P429808338
   PubMed Web of Science ®Google Scholar
• HurelbrinkCBBarkerRAThe potential of GDNF as a treatment for Parkinson’s diseaseExp Neurol20041851614697313
   PubMed Web of Science ®Google Scholar
• WangYXuHFuQMaRXiangJProtective effect of resveratrol derived from Polygonum cuspidatum and its liposomal form on nigral cells in parkinsonian ratsJ Neurol Sci2011304293421376343
   PubMed Web of Science ®Google Scholar
• AmicarelliFGasbarriAMascioccoLThe effect of intrastriatal injection of liposome-entrapped tyrosinase on the dopamine levels in the rat brainCell Mol Biol (Noisy-le-Grand)1999451093109710644014
   PubMed Web of Science ®Google Scholar
• SegoviaJVergaraPBrennerMAstrocyte-specific expression of tyrosine hydroxylase after intracerebral gene transfer induces behavioral recovery in experimental parkinsonismGene Ther199851650165510023444
   PubMed Web of Science ®Google Scholar
• ImaokaTDateIOhmotoTNagatsuTSignificant behavioral recovery in Parkinson’s disease model by direct intracerebral gene transfer using continuous injection of a plasmid DNA-liposome complexHum Gene Ther19989109311029607420
   PubMed Web of Science ®Google Scholar
• DuringMJFreeseADeutchAYBiochemical and behavioral recovery in a rodent model of Parkinson’s disease following stereotactic implantation of dopamine-containing liposomesExp Neurol19921151931991735466
   PubMed Web of Science ®Google Scholar
• Campos-RomoAOjeda-FloresRMoreno-BriseñoPBehavioral improvement in MPTP-treated nonhuman primates in the HALLWAY task after transfer of TH cDNA to host astrocytesActa Neurobiol Exp (Wars)20127216617622810218
   PubMedGoogle Scholar
• GoASMozaffarianDRogerVLExecutive summary: heart disease and stroke statistics – 2014 update: a report from the American Heart AssociationCirculation201412939941024446411
   PubMed Web of Science ®Google Scholar
• LoEHDalkaraTMoskowitzMAMechanisms, challenges and opportunities in strokeNat Rev Neurosci2003439941512728267
   PubMed Web of Science ®Google Scholar
• YanJZhengMZhangDChrysophanol liposome preconditioning protects against cerebral ischemia-reperfusion injury by inhibiting oxidative stress and apoptosis in miceInt J Pharmacol2014105568
   Google Scholar
• DeddensLHvan TilborgGAvan der ToornAMRI of ICAM-1 upregulation after stroke: the importance of choosing the appropriate target-specific particulate contrast agentMol Imaging Biol20131541142223400400
   PubMed Web of Science ®Google Scholar
• LiuSZhenGLiRCDoréSAcute bioenergetic intervention or pharmacological preconditioning protects neuron against ischemic injuryJ Exp Stroke Transl Med2013671724285991
   PubMedGoogle Scholar
• YunXMaximovVDYuJZhuHVertegelAAKindyMSNanoparticles for targeted delivery of antioxidant enzymes to the brain after cerebral ischemia and reperfusion injuryJ Cereb Blood Flow Metab20133358359223385198
   PubMed Web of Science ®Google Scholar
• DvoriantchikovaGBarakatDJHernandezEShestopalovVIIvanovDLiposome-delivered ATP effectively protects the retina against ischemia-reperfusion injuryMol Vis2010162882289021203410
   PubMed Web of Science ®Google Scholar
• DvoriantchikovaGAgudeloCHernandezEShestopalovVIIvanovDPhosphatidylserine-containing liposomes promote maximal survival of retinal neurons after ischemic injuryJ Cereb Blood Flow Metab2009291755175919675564
   PubMed Web of Science ®Google Scholar
• ChanPHAntioxidant-dependent amelioration of brain injury: role of CuZn-superoxide dismutaseJ Neurotrauma19929S417S423
   PubMedGoogle Scholar
• HwangHJeongHSOhPSImproving cerebral blood flow through liposomal delivery of angiogenic peptides: potential of 18F-FDG PET imaging in ischemic stroke treatmentJ Nucl Med2015561106111125977466
   PubMed Web of Science ®Google Scholar
• WangZZhaoYJiangYEnhanced anti-ischemic stroke of ZL006 by T7-conjugated PEGylated liposomes drug delivery systemSci Rep201551265126219474
   PubMed Web of Science ®Google Scholar
• AgullaJBreaDCamposFIn vivo theranostics at the peri-infarct region in cerebral ischemiaTheranostics2014490105
   Web of Science ®Google Scholar
• FukutaTIshiiTAsaiTReal-time trafficking of PEGylated liposomes in the rodent focal brain ischemia analyzed by positron emission tomographyArtif Organs20143866266625295359
   PubMed Web of Science ®Google Scholar
• KanedaSIshizukaTSekiguchiAMorimotoKKasukawaHEfficacy of liposome-encapsulated hemoglobin in a rat model of cerebral ischemiaArtif Organs20143865065525132081
   PubMed Web of Science ®Google Scholar
• KawaguchiATEndoHAikawaHEffects of liposome-encapsulated hemoglobin on learning ability in Tokai high-avoider rat after total brain ischemia and reperfusionArtif Organs20143866767425066829
   PubMedGoogle Scholar
• KimHBrittonGLPengTNitric oxide-loaded echogenic liposomes for treatment of vasospasm following subarachnoid hemorrhageInt J Nanomedicine2013915516524379666
   PubMedGoogle Scholar
• ShimboDAbumiyaTShichinoheHNakayamaNKazumataKHoukinKPost-ischemic intra-arterial infusion of liposome-encapsulated hemoglobin can reduce ischemia reperfusion injuryBrain Res20141554596624486612
   PubMedGoogle Scholar
• IshiiTFukutaTAgatoYNanoparticles accumulate in ischemic core and penumbra region even when cerebral perfusion is reducedBiochem Biophys Res Commun20134301201120523268342
   PubMedGoogle Scholar
• IshiiTAsaiTOyamaDTreatment of cerebral ischemia-reperfusion injury with PEGylated liposomes encapsulating FK506FASEB J2013271362137023241312
   PubMed Web of Science ®Google Scholar
• PengTBrittonGLKimHTherapeutic time window and dose dependence of xenon delivered via echogenic liposomes for neuroprotection in strokeCNS Neurosci Ther20131977378423981565
   PubMed Web of Science ®Google Scholar
• QuCNiJYangPAltered plasma and brain disposition of isopropylidene shikimic acid liposome in rats and the brain protection in cerebral ischemia-reperfusionDrug Dev Ind Pharm2013391291129523020069
   PubMed Web of Science ®Google Scholar
• IshiiTAsaiTOyamaDAmelioration of cerebral ischemia-reperfusion injury based on liposomal drug delivery system with asialo-erythropoietinJ Control Release2012160818722342472
   PubMed Web of Science ®Google Scholar
• IshiiTAsaiTFukutaTA single injection of liposomal asialo-erythropoietin improves motor function deficit caused by cerebral ischemia/reperfusionInt J Pharm201243926927422989979
   PubMedGoogle Scholar
• TieboschIACrielaardBJBoutsMJCombined treatment with recombinant tissue plasminogen activator and dexamethasone phosphate-containing liposomes improves neurological outcome and restricts lesion progression after embolic stroke in ratsJ Neurochem2012123657423050644
   PubMedGoogle Scholar
• Ramos-CabrerPAgullaJArgibayBPérez-MatoMCastilloJSerial MRI study of the enhanced therapeutic effects of liposome-encapsulated citicoline in cerebral ischemiaInt J Pharm201140522823321168478
   PubMed Web of Science ®Google Scholar
• ZhaoGZangSYJiangZHPostischemic administration of liposome-encapsulated luteolin prevents against ischemia-reperfusion injury in a rat middle cerebral artery occlusion modelJ Nutr Biochem20112292993621190830
   PubMed Web of Science ®Google Scholar
• ZhaoHBaoXJWangRZPostacute ischemia vascular endothelial growth factor transfer by transferrin-targeted liposomes attenuates ischemic brain injury after experimental stroke in ratsHum Gene Ther20112220721521128742
   PubMed Web of Science ®Google Scholar
• BrittonGLKimHKeePHIn vivo therapeutic gas delivery for neuroprotection with echogenic liposomesCirculation20101221578158720921443
   PubMed Web of Science ®Google Scholar
• GhoshSDasNMandalAKDungdungSRSarkarSMannosylated liposomal cytidine 5′ diphosphocholine prevent age related global moderate cerebral ischemia reperfusion induced mitochondrial cytochrome C release in aged rat brainNeuroscience20101711287129920883746
   PubMed Web of Science ®Google Scholar
• HamadateNYamaguchiTSugawaraALiposome-encapsulated hemoglobin ameliorates impairment of fear memory and hippocampal dysfunction after cerebral ischemia in ratsJ Pharmacol Sci201011440941921076236
   PubMed Web of Science ®Google Scholar
• KakehataJYamaguchiTTogashiHTherapeutic potentials of an artificial oxygen-carrier, liposome-encapsulated hemoglobin, for ischemia/reperfusion-induced cerebral dysfunction in ratsJ Pharmacol Sci201011418919720838027
   PubMed Web of Science ®Google Scholar
• FukumotoDKawaguchiATHaidaMYamanoMOgataYTsukadaHLiposome-encapsulated hemoglobin reduces the size of cerebral infarction in rats: effect of oxygen affinityArtif Organs20093315916319178461
   PubMed Web of Science ®Google Scholar
• KawaguchiATKuritaDFuruyaHYamanoMOgataYHaidaMLiposome-encapsulated hemoglobin alleviates brain edema after permanent occlusion of the middle cerebral artery in ratsArtif Organs20093315315819178460
   PubMedGoogle Scholar
• UrakamiTKawaguchiATAkaiSIn vivo distribution of liposome-encapsulated hemoglobin determined by positron emission tomographyArtif Organs20093316416819178462
   PubMed Web of Science ®Google Scholar
• OmaeTYoshiokaHTanakaTAntisense in vivo knockdown of synaptotagmin I by HVJ-liposome mediated gene transfer attenuates ischemic brain damage in neonatal ratsBrain Dev20083031332018358657
   PubMedGoogle Scholar
• RiveraFCostaGAbinAReduction of ischemic brain damage and increase of glutathione by a liposomal preparation of quercetin in permanent focal ischemia in ratsNeurotox Res20081310511418515213
   PubMed Web of Science ®Google Scholar
• KawaguchiATFukumotoDHaidaMOgataYYamanoMTsukadaHLiposome-encapsulated hemoglobin reduces the size of cerebral infarction in the rat: evaluation with photochemically induced thrombosis of the middle cerebral arteryStroke2007381626163217395856
   PubMed Web of Science ®Google Scholar
• SarkarSDasNMannosylated liposomal flavonoid in combating age-related ischemia-reperfusion induced oxidative damage in rat brainMech Ageing Dev200612739139716480758
   PubMed Web of Science ®Google Scholar
• AdibhatlaRMHatcherJFTureyenKCDP-choline liposomes provide significant reduction in infarction over free CDP-choline in strokeBrain Res2005105819319716153613
   PubMed Web of Science ®Google Scholar
• LukYOChenWYWongWJTreatment of focal cerebral ischemia with liposomal nerve growth factorDrug Deliv20041131932415742557
   PubMed Web of Science ®Google Scholar
• OdaTKimuraTOgataYFujiseYHemodilution with liposome-encapsulated low-oxygen-affinity hemoglobin does not attenuate hypothermic cerebral ischemia in ratsJ Artif Organs2005826326916362525
   PubMedGoogle Scholar
• AsahiMRammohanRSumiiTAntiactin-targeted immunoliposomes ameliorate tissue plasminogen activator-induced hemorrhage after focal embolic strokeJ Cereb Blood Flow Metab20032389589912902833
   PubMed Web of Science ®Google Scholar
• OmoriNMaruyamaKJinGTargeting of post-ischemic cerebral endothelium in rat by liposomes bearing polyethylene glycol-coupled transferrinNeurol Res20032527527912739237
   PubMed Web of Science ®Google Scholar
• CaoYJShibataTRainovNLiposome-mediated transfer of the bcl-2 gene results in neuroprotection after in vivo transient focal cerebral ischemia in an animal modelGene Ther2002941541911960318
   PubMed Web of Science ®Google Scholar
• SinhaJDasNBasuMKLiposomal antioxidants in combating ischemia-reperfusion injury in rat brainBiomed Pharmacother20015526427111428552
   PubMed Web of Science ®Google Scholar
• TakanashiYIshidaTKirchmeierMJShuaibAAllenTMNeuroprotection by intrathecal application of liposome-entrapped fasudil in a rat model of ischemiaNeurol Med Chir (Tokyo)20014110711411372552
   PubMed Web of Science ®Google Scholar
• FrestaMPuglisiGReduction of maturation phenomenon in cerebral ischemia with CDP-choline-loaded liposomesPharm Res1999161843184910644072
   PubMed Web of Science ®Google Scholar
• YokotaMTaniETsubukiSCalpain inhibitor entrapped in liposome rescues ischemic neuronal damageBrain Res199981981410082855
   PubMedGoogle Scholar
• FrestaMPuglisiGSurvival rate improvement in a rat ischemia model by long circulating liposomes containing cytidine-5I-diphosphate cholineLife Sci199761122712359324064
   PubMed Web of Science ®Google Scholar
• FrestaMBiological effects of CDP-choline loaded long circulating liposomes on rat cerebral post-ischemic reperfusionInt J Pharm19961348997
   Web of Science ®Google Scholar
• FrestaMWehrliEPuglisiGEnhanced therapeutic effect of cytidine-5′-diphosphate choline when associated with GM1 containing small liposomes as demonstrated in a rat ischemia modelPharm Res199512176917748592684
   PubMed Web of Science ®Google Scholar
• FrestaMPuglisiGDi GiacomoCRussoALiposomes as in-vivo carriers for citicoline: effects on rat cerebral post-ischaemic reperfusionJ Pharm Pharmacol1994469749817714721
   PubMed Web of Science ®Google Scholar
• PuisieuxFFattalELahianiMLiposomes, an interesting tool to deliver a bioenergetic substrate (ATP): in vitro and in vivo studiesJ Drug Target199424434487704489
   PubMed Web of Science ®Google Scholar
• ChapatSFreyVClaperonNEfficiency of liposomal ATP in cerebral ischemia: bioavailability featuresBrain Res Bull1991263393422049600
   PubMed Web of Science ®Google Scholar
• PhelanAMLangeDGIschemia/reperfusion-induced changes in membrane fluidity characteristics of brain capillary endothelial cells and its prevention by liposomal-incorporated superoxide dismutaseBiochim Biophys Acta19911067971021651115
   PubMedGoogle Scholar
• ImaizumiSWoolworthVFishmanRAChanPHLiposome-entrapped superoxide dismutase reduces cerebral infarction in cerebral ischemia in ratsStroke199021131213172396268
   PubMed Web of Science ®Google Scholar
• LahamAClaperonNDurusselJJIntracarotidal administration of liposomally-entrapped ATP: improved efficiency against experimental brain ischemiaPharmacol Res Commun1988206997053212008
   PubMedGoogle Scholar
• LahamAClaperonNDurusselJJLiposomally entrapped adenosine triphosphate: improved efficiency against experimental brain ischaemia in the ratJ Chromatogr19884404554583403671
   PubMed Web of Science ®Google Scholar
• ChanPHFishmanRAWesleyMALongarSPathogenesis of vasogenic edema in focal cerebral ischemia: role of superoxide radicalsAdv Neurol1990521771832168662
   PubMedGoogle Scholar
• BigonEBoaratoEBruniALeonAToffanoGPharmacological effects of phosphatidylserine liposomes: regulation of glycolysis and energy level in brainBr J Pharmacol197966167174465867
   PubMedGoogle Scholar
• KomatsuHFuruyaTSatoNEffect of hemoglobin vesicle, a cellular-type artificial oxygen carrier, on middle cerebral artery occlusion- and arachidonic acid-induced stroke models in ratsNeurosci Lett200742112112517566655
   PubMedGoogle Scholar
• StanimirovicDBMarkovicMMicicDVSpatzMMrsuljaBBLiposome-entrapped superoxide dismutase reduces ischemia/reperfusion ‘oxidative stress’ in gerbil brainNeurochem Res199419147314787877716
   PubMed Web of Science ®Google Scholar
• KawaguchiATHaidaMOhbaHYamanoMFukumotoDTsukadaHLiposome-encapsulated hemoglobin ameliorates ischemic stroke in nonhuman primates: longitudinal observationArtif Organs20133790491223647614
   PubMedGoogle Scholar
• KawaguchiATHaidaMYamanoMFukumotoDOgataYTsukadaHLiposome-encapsulated hemoglobin ameliorates ischemic stroke in nonhuman primates: an acute studyJ Pharmacol Exp Ther201033242943619910538
   PubMed Web of Science ®Google Scholar
• WardlawJMMurrayVBergeERecombinant tissue plasminogen activator for acute ischaemic stroke: an updated systematic review and meta-analysisLancet20123792364237222632907
   PubMed Web of Science ®Google Scholar
• LichtmanJHKrumholzHMWangYRadfordMJBrassLMRisk and predictors of stroke after myocardial infarction among the elderly: results from the Cooperative Cardiovascular ProjectCirculation20021051082108711877359
   PubMed Web of Science ®Google Scholar
• OvergaardKThe effects of citicoline on acute ischemic stroke: a reviewJ Stroke Cerebrovasc Dis2014231764176924739589
   PubMed Web of Science ®Google Scholar
• SecadesJCiticoline: pharmacological and clinical review – 2010 updateRev Neurol201152S1S62
   PubMed Web of Science ®Google Scholar
• NavaratnaDGuoSAraiKLoEHMechanisms and targets for angiogenic therapy after strokeCell Adh Migr2009321622319363301
   PubMed Web of Science ®Google Scholar
• SchwartzbaumJAFisherJLAldapeKDWrenschMEpidemiology and molecular pathology of gliomaNat Clin Pract Neurol2006249450316932614
   PubMedGoogle Scholar
• MinnitiGDe SanctisVMuniRRadiotherapy plus concomitant and adjuvant temozolomide for glioblastoma in elderly patientsJ Neurooncol2008889710318250965
   PubMed Web of Science ®Google Scholar
• WeiXChenXYingMLuWBrain tumor-targeted drug delivery strategiesActa Pharm Sin B2014419320126579383
   PubMed Web of Science ®Google Scholar
• JuRJZengFLiuLDestruction of vasculogenic mimicry channels by targeting epirubicin plus celecoxib liposomes in treatment of brain gliomaInt J Nanomedicine2016111131114627042063
   PubMed Web of Science ®Google Scholar
• LiuYMeiLXuCDual receptor recognizing cell penetrating peptide for selective targeting, efficient intratumoral diffusion and synthesized anti-glioma therapyTheranostics2016617719126877777
   PubMed Web of Science ®Google Scholar
• ShiKLongYXuCLiposomes combined an integrin αvβ3-specific vector with pH-responsible cell-penetrating property for highly effective antiglioma therapy through the blood-brain barrierACS Appl Mater Interfaces20157214422145426371468
   PubMed Web of Science ®Google Scholar
• CostaPMCardosoALCustódiaCMiRNA-21 silencing mediated by tumor-targeted nanoparticles combined with sunitinib: a new multimodal gene therapy approach for glioblastomaJ Control Release2015207313925861727
   PubMed Web of Science ®Google Scholar
• LiuYMeiLYuQMultifunctional tandem peptide modified paclitaxel-loaded liposomes for the treatment of vasculogenic mimicry and cancer stem cells in malignant gliomaACS Appl Mater Interfaces20157167921680126173814
   PubMed Web of Science ®Google Scholar
• Pacheco-TorresJMukherjeeNWalkoMImage guided drug release from pH-sensitive ion channel-functionalized stealth liposomes into an in vivo glioblastoma modelNanomedicine2015111345135425888277
   PubMed Web of Science ®Google Scholar
• PeirisPMAbramowskiAMcginnityJTreatment of invasive brain tumors using a chain-like nanoparticleCancer Res2015751356136525627979
   PubMed Web of Science ®Google Scholar
• LiXTJuRJLiXYMultifunctional targeting daunorubicin plus quinacrine liposomes, modified by wheat germ agglutinin and tamoxifen, for treating brain glioma and glioma stem cellsOncotarget201456497651125153726
   PubMed Web of Science ®Google Scholar
• QinLWangCZFanHJA dual-targeting liposome conjugated with transferrin and arginine-glycine-aspartic acid peptide for glioma-targeting therapyOncol Lett201482000200625289086
   PubMed Web of Science ®Google Scholar
• YangZXiangBDongDWangZLiJQiXDual receptor-specific peptides modified liposomes as VEGF siRNA vector for tumor-targeting therapyCurr Gene Ther20141428929925039617
   PubMedGoogle Scholar
• ZongTMeiLGaoHEnhanced glioma targeting and penetration by dual-targeting liposome co-modified with T7 and TATJ Pharm Sci20141033891390125339554
   PubMed Web of Science ®Google Scholar
• ChenPYOzawaTDrummondDCComparing routes of delivery for nanoliposomal irinotecan shows superior anti-tumor activity of local administration in treating intracranial glioblastoma xenograftsNeuro Oncol20131518919723262509
   PubMed Web of Science ®Google Scholar
• CostaPMCardosoALMendonçaLSTumor-targeted chlorotoxin-coupled nanoparticles for nucleic acid delivery to glioblastoma cells: a promising system for glioblastoma treatmentMol Ther Nucleic Acids20132e10023778499
   PubMedGoogle Scholar
• YangYYanZWeiDTumor-penetrating peptide functionalization enhances the anti-glioblastoma effect of doxorubicin liposomesNanotechnology20132440510124029287
   PubMed Web of Science ®Google Scholar
• HuangYZhouDHangTPreparation, characterization, and assessment of the antiglioma effects of liposomal celastrolAnticancer Drugs20122351552422343423
   PubMed Web of Science ®Google Scholar
• GongWWangZLiuNImproving efficiency of adriamycin crossing blood brain barrier by combination of thermosensitive liposomes and hyperthermiaBiol Pharm Bull2011341058106421720013
   PubMed Web of Science ®Google Scholar
• MeiDYGaoHLGongWHPangZQJiangXGChenJAnti-glioma effect of doxorubicin loaded liposomes modified with angiopep-2Afr J Pharm Pharmacol20115409414
   Web of Science ®Google Scholar
• SerwerLPNobleCOMichaudKInvestigation of intravenous delivery of nanoliposomal topotecan for activity against orthotopic glioblastoma xenograftsNeuro Oncol2011131288129521954443
   PubMedGoogle Scholar
• XiangYLiangLWangXWangJZhangXZhangQChloride channel-mediated brain glioma targeting of chlorotoxin-modified doxorubicine-loaded liposomesJ Control Release201115240241021435361
   PubMed Web of Science ®Google Scholar
• FengBTomizawaKMichiueHDelivery of sodium borocaptate to glioma cells using immunoliposome conjugated with anti-EGFR antibodies by ZZ-HisBiomaterials2009301746175519121537
   PubMed Web of Science ®Google Scholar
• MadhankumarABSlagle-WebbBWangXEfficacy of interleukin-13 receptor-targeted liposomal doxorubicin in the intracranial brain tumor modelMol Cancer Ther2009864865419276162
   PubMed Web of Science ®Google Scholar
• DoiAKawabataSIidaKTumor-specific targeting of sodium borocaptate (BSH) to malignant glioma by transferrin-PEG liposomes: a modality for boron neutron capture therapyJ Neurooncol20088728729418219552
   PubMed Web of Science ®Google Scholar
• AbounaderRLalBLuddyCIn vivo targeting of SF/HGF and c-met expression via U1snRNA/ribozymes inhibits glioma growth and angiogenesis and promotes apoptosisFASEB J20021610811011729097
   PubMed Web of Science ®Google Scholar
• LinQMaoKLTianFRBrain tumor-targeted delivery and therapy by focused ultrasound introduced doxorubicin-loaded cationic liposomesCancer Chemother Pharmacol20167726928026666650
   PubMed Web of Science ®Google Scholar
• MabuchiEShimizuKMiyaoYGene delivery by HVJ-liposome in the experimental gene therapy of murine gliomaGene Ther199747687729338004
   PubMed Web of Science ®Google Scholar
• AryalMParkJVykhodtsevaNZhangYZMcDannoldNEnhancement in blood-tumor barrier permeability and delivery of liposomal doxorubicin using focused ultrasound and microbubbles: evaluation during tumor progression in a rat glioma modelPhys Med Biol2015602511252725746014
   PubMed Web of Science ®Google Scholar
• HuangFYLeeTWChangCHEvaluation of 188Re-labeled PEGylated nanoliposome as a radionuclide therapeutic agent in an orthotopic glioma-bearing rat modelInt J Nanomedicine20151046347325624760
   PubMed Web of Science ®Google Scholar
• Mendiburu-EliçabeMGil-RanedoJCombination therapy of intraperitoneal rapamycin and convection-enhanced delivery of nanoliposomal CPT-11 in rodent orthotopic brain tumor xenograftsCurr Cancer Drug Targets20151535236225714699
   PubMedGoogle Scholar
• QiuLHZhangJWLiSPMolecular imaging of angiogenesis to delineate the tumor margins in glioma rat model with endoglin-targeted paramagnetic liposomes using 3T MRIJ Magn Reson Imaging2015411056106424677456
   PubMedGoogle Scholar
• RollerBTMunsonJMBrahmaBSantangeloPJPaiSBBellamkondaRVEvans blue nanocarriers visually demarcate margins of invasive gliomasDrug Deliv Transl Res2015511612425787737
   PubMedGoogle Scholar
• SheinSANukolovaNVKorchaginaAASite-directed delivery of VEGF-targeted liposomes into intracranial C6 gliomaBull Exp Biol Med201515837137625573371
   PubMed Web of Science ®Google Scholar
• LiXYZhaoYSunMGMultifunctional liposomes loaded with paclitaxel and artemether for treatment of invasive brain gliomaBiomaterials2014355591560424726749
   PubMed Web of Science ®Google Scholar
• NobleCOKrauzeMTDrummondDCPharmacokinetics, tumor accumulation and antitumor activity of nanoliposomal irinotecan following systemic treatment of intracranial tumorsNanomedicine (Lond)201492099210824494810
   PubMed Web of Science ®Google Scholar
• YuePJHeLQiuSWOX26/CTX-conjugated PEGylated liposome as a dual-targeting gene delivery system for brain gliomaMol Cancer20141319125128329
   PubMed Web of Science ®Google Scholar
• CharestGSancheLFortinDMathieuDPaquetteBOptimization of the route of platinum drugs administration to optimize the concomitant treatment with radiotherapy for glioblastoma implanted in the Fischer rat brainJ Neurooncol201311536537324026531
   PubMed Web of Science ®Google Scholar
• GaoJQLvQLiLMGlioma targeting and blood-brain barrier penetration by dual-targeting doxorubincin [sic] liposomesBiomaterials2013345628563923628475
   PubMed Web of Science ®Google Scholar
• ChekhoninVPBaklaushevVPYusubalievaGMTargeted delivery of liposomal nanocontainers to the peritumoral zone of glioma by means of monoclonal antibodies against GFAP and the extracellular loop of Cx43Nanomedicine20128637021703991
   PubMed Web of Science ®Google Scholar
• HuoTBarthRFYangWPreparation, biodistribution and neurotoxicity of liposomal cisplatin following convection enhanced delivery in normal and F98 glioma bearing ratsPLoS One20127e4875223152799
   PubMed Web of Science ®Google Scholar
• MunsonJMFriedLRowsonSAAnti-invasive adjuvant therapy with imipramine blue enhances chemotherapeutic efficacy against gliomaSci Transl Med20124127ra36
   PubMed Web of Science ®Google Scholar
• PhillipsWTGoinsBBaoARhenium-186 liposomes as convection-enhanced nanoparticle brachytherapy for treatment of glioblastomaNeuro Oncol20121441642522427110
   PubMed Web of Science ®Google Scholar
• TreatLHMcDannoldNZhangYVykhodtsevaNHynynenKImproved anti-tumor effect of liposomal doxorubicin after targeted blood-brain barrier disruption by MRI-guided focused ultrasound in rat gliomaUltrasound Med Biol2012381716172522818878
   PubMed Web of Science ®Google Scholar
• ChenHQinYZhangQLactoferrin modified doxorubicin-loaded procationic liposomes for the treatment of gliomasEur J Pharm Sci20114416417321782939
   PubMed Web of Science ®Google Scholar
• HuangFYLeeTWKaoCHImaging, autoradiography, and biodistribution of 188 re-labeled PEGylated nanoliposome in orthotopic glioma bearing rat modelCancer Biother Radiopharm20112671772522145660
   PubMedGoogle Scholar
• MiyataSKawabataSHiramatsuRComputed tomography imaging of transferrin targeting liposomes encapsulating both boron and iodine contrast agents by convection-enhanced delivery to F98 rat glioma for boron neutron capture therapyNeurosurgery2011681380138721273928
   PubMed Web of Science ®Google Scholar
• OkuNYamashitaMKatayamaYPET imaging of brain cancer with positron emitter-labeled liposomesInt J Pharm201140317017720934495
   PubMed Web of Science ®Google Scholar
• QinYChenHZhangQLiposome formulated with TAT-modified cholesterol for improving brain delivery and therapeutic efficacy on brain glioma in animalsInt J Pharm201142030431221945185
   PubMed Web of Science ®Google Scholar
• TianWYingXDuJEnhanced efficacy of functionalized epirubicin liposomes in treating brain glioma-bearing ratsEur J Pharm Sci20104123224320600880
   PubMed Web of Science ®Google Scholar
• YingXWenHLuWLDual-targeting daunorubicin liposomes improve the therapeutic efficacy of brain glioma in animalsJ Control Release201014118319219799948
   PubMed Web of Science ®Google Scholar
• DuJLuWLYingXDual-targeting topotecan liposomes modified with tamoxifen and wheat germ agglutinin significantly improve drug transport across the blood-brain barrier and survival of brain tumor-bearing animalsMol Pharm2009690591719344115
   PubMed Web of Science ®Google Scholar
• GrahnAYBankiewiczKSDugich-DjordjevicMNon-PEGylated liposomes for convection-enhanced delivery of topotecan and gadodiamide in malignant glioma: initial experienceJ Neurooncol20099518519719466380
   PubMedGoogle Scholar
• ZhangDFengXYHenningTDMR imaging of tumor angiogenesis using sterically stabilized Gd-DTPA liposomes targeted to CD105Eur J Radiol20097018018918541399
   PubMedGoogle Scholar
• KarathanasisEParkJAgarwalAMRI mediated, non-invasive tracking of intratumoral distribution of nanocarriers in rat gliomaNanotechnology20081931510121828778
   PubMedGoogle Scholar
• ZhaoSZhangXZhangJIntravenous administration of arsenic trioxide encapsulated in liposomes inhibits the growth of C6 gliomas in rat brainsJ Chemother20082025326218467254
   PubMed Web of Science ®Google Scholar
• HuynhGHOzawaTDeenDFTihanTSzokaFCJrRetro-convection enhanced delivery to increase blood to brain transfer of macromoleculesBrain Res2007112818119017125752
   PubMedGoogle Scholar
• KrauzeMTNobleCOKawaguchiTConvection-enhanced delivery of nanoliposomal CPT-11 (irinotecan) and PEGylated liposomal doxorubicin (Doxil) in rodent intracranial brain tumor xenograftsNeuro Oncol2007939340317652269
   PubMed Web of Science ®Google Scholar
• YamashitaYKrauzeMTKawaguchiTConvection-enhanced delivery of a topoisomerase I inhibitor (nanoliposomal topotecan) and a topoisomerase II inhibitor (PEGylated liposomal doxorubicin) in intracranial brain tumor xenograftsNeuro Oncol20069202817018695
   PubMedGoogle Scholar
• NobleCOKrauzeMTDrummondDCNovel nanoliposomal CPT-11 infused by convection-enhanced delivery in intracranial tumors: pharmacology and efficacyCancer Res2006662801280616510602
   PubMed Web of Science ®Google Scholar
• SaitoRConvection-enhanced delivery of Ls-TPT enables an effective, continuous, low-dose chemotherapy against malignant glioma xenograft modelNeuro Oncol2006820521416723630
   PubMed Web of Science ®Google Scholar
• MamotCNguyenJBPourdehnadMExtensive distribution of liposomes in rodent brains and brain tumors following convection-enhanced deliveryJ Neurooncol2004681915174514
   PubMed Web of Science ®Google Scholar
• SaitoRBringasJRMcKnightTRDistribution of liposomes into brain and rat brain tumor models by convection-enhanced delivery monitored with magnetic resonance imagingCancer Res2004642572257915059914
   PubMed Web of Science ®Google Scholar
• ZhangYBoadoRJPardridgeWMIn vivo knockdown of gene expression in brain cancer with intravenous RNAi in adult ratsJ Gene Med200351039104514661179
   PubMed Web of Science ®Google Scholar
• JiangFLilgeLGrenierJLiYWilsonMDChoppMPhotodynamic therapy of U87 human glioma in nude rat using liposome-delivered photofrinLasers Surg Med19982274809484699
   PubMedGoogle Scholar
• HoSYBarbareseED’ArrigoJSSmith-SlatasCSimonRHEvaluation of lipid-coated microbubbles as a delivery vehicle for Taxol in brain tumor therapyNeurosurgery199740126012689179900
   PubMed Web of Science ®Google Scholar
• JiangFLilgeLLogieBLiYChoppMPhotodynamic therapy of 9L gliosarcoma with liposome-delivered photofrinPhotochem Photobiol1997657017069114747
   PubMedGoogle Scholar
• SharmaUSSharmaAChauRIStraubingerRMLiposome-mediated therapy of intracranial brain tumors in a rat modelPharm Res1997149929989279878
   PubMed Web of Science ®Google Scholar
• KakinumaKTanakaRTakahashiHWatanabeMNakagawaTKurokiMTargeting chemotherapy for malignant brain tumor using thermosensitive liposome and localized hyperthermiaJ Neurosurg1996841801848592219
   PubMed Web of Science ®Google Scholar
• BarbareseEHoSYD’ArrigoJSSimonRHInternalization of microbubbles by tumor cells in vivo and in vitroJ Neurooncol19952625348583242
   PubMed Web of Science ®Google Scholar
• ShibataSOchiAMoriKLiposomes as carriers of cisplatin into the central nervous system: experiments with 9L gliomas in ratsNeurol Med Chir (Tokyo)1990302422451696693
   PubMedGoogle Scholar
• ZhangHWenYMaoBGongQQianZWeiYPlasmid encoding matrix protein of vesicular stomatitis viruses as an antitumor agent inhibiting rat glioma growth in situExp Oncol200729859317704738
   PubMedGoogle Scholar
• DickinsonPJLeCouteurRAHigginsRJCanine spontaneous glioma: a translational model system for convection-enhanced deliveryNeuro Oncol20101292894020488958
   PubMedGoogle Scholar
• KrauzeMTMcknightTRYamashitaYReal-time visualization and characterization of liposomal delivery into the monkey brain by magnetic resonance imagingBrain Res Brain Res Protoc200516202616181805
   PubMedGoogle Scholar
• WakabayashiTNatsumeAHashizumeYFujiiMMizunoMYoshidaJA phase I clinical trial of interferon-beta gene therapy for high-grade glioma: novel findings from gene expression profiling and autopsyJ Gene Med20081032933918220319
   PubMed Web of Science ®Google Scholar
• FiorilloAMaggiGGrecoNSecond-line chemotherapy with the association of liposomal daunorubicin, carboplatin and etoposide in children with recurrent malignant brain tumorsJ Neurooncol20046617918515015784
   PubMedGoogle Scholar
• YoshidaJMizunoMFujiiMHuman gene therapy for malignant gliomas (glioblastoma multiforme and anaplastic astrocytoma) by in vivo transduction with human interferon beta gene using cationic liposomesHum Gene Ther200415778614965379
   PubMed Web of Science ®Google Scholar
• RenHBoulikasTLundstromKSölingAWarnkePCRainovNGImmunogene therapy of recurrent glioblastoma multiforme with a liposomally encapsulated replication-incompetent Semliki forest virus vector carrying the human interleukin-12 gene: a phase I/II clinical protocolJ Neurooncol20036414715412952295
   PubMed Web of Science ®Google Scholar
• AlbrechtKWde Witt HamerPCLeenstraSHigh concentration of daunorubicin and daunorubicinol in human malignant astrocytomas after systemic administration of liposomal daunorubicinJ Neurooncol20015326727111718259
   PubMed Web of Science ®Google Scholar
• FabelKDietrichJHauPLong-term stabilization in patients with malignant glioma after treatment with liposomal doxorubicinCancer2001921936194211745268
   PubMed Web of Science ®Google Scholar
• KoukourakisMIKoukourakiSFezoulidisIHigh intratumoural accumulation of stealth liposomal doxorubicin (Caelyx) in glioblastomas and in metastatic brain tumoursBr J Cancer2000831281128611044350
   PubMed Web of Science ®Google Scholar
• ZucchettiMBoiardiASilvaniAParisiIPiccolrovazziSD’IncalciMDistribution of daunorubicin and daunorubicinol in human glioma tumors after administration of liposomal daunorubicinCancer Chemother Pharmacol19994417317610412954
   PubMed Web of Science ®Google Scholar
• FirthGBFirthMMcKeranROApplication of radioimmunoassay to monitor treatment of human cerebral gliomas with bleomycin entrapped within liposomesJ Clin Pathol19884138432449466
   PubMed Web of Science ®Google Scholar
• McKeranROFirthGOliverSUttleyDO’LaoireSA potential application for the intracerebral injection of drugs entrapped within liposomes in the treatment of human cerebral gliomasJ Neurol Neurosurg Psychiatry198548121312192418156
   PubMedGoogle Scholar
• ChapmanSDobrovolskaiaMFarahaniKNanoparticles for cancer imaging: the good, the bad, and the promiseNano Today2013845446025419228
   PubMed Web of Science ®Google Scholar
• KeunenOTaxtTGrünerRMultimodal imaging of gliomas in the context of evolving cellular and molecular therapiesAdv Drug Deliv Rev2014769811525078721
   PubMed Web of Science ®Google Scholar
• Hernández-PedroNYRangel-LópezEMagaña-MaldonadoRApplication of nanoparticles on diagnosis and therapy in gliomasBiomed Res Int2013201335103123691498
   PubMed Web of Science ®Google Scholar
• BlasiakBvan VeggelFCTomanekBApplications of nanoparticles for MRI cancer diagnosis and therapyJ Nanomater20132013148578
   Google Scholar
• HaglundMMBergerMSHochmanDWEnhanced optical imaging of human gliomas and tumor marginsNeurosurgery1996383083178869058
   PubMed Web of Science ®Google Scholar
• MinnHPET and SPECT in low-grade gliomaEur J Radiol20055617117816233891
   PubMed Web of Science ®Google Scholar
• la FougèreCSuchorskaBBartensteinPKrethFWTonnJCMolecular imaging of gliomas with PET: opportunities and limitationsNeuro Oncol20111380681921757446
   PubMed Web of Science ®Google Scholar
• AndersonJCMcFarlandBCGladsonCLNew molecular targets in angiogenic vessels of glioblastoma tumoursExpert Rev Mol Med200810e2318684337
   PubMedGoogle Scholar
• BaskarRLeeKAYeoRYeohKWCancer and radiation therapy: current advances and future directionsInt J Med Sci2012919319922408567
   PubMed Web of Science ®Google Scholar
• Werner-WasikMScottCBNelsonDFFinal report of a phase I/II trial of hyperfractionated and accelerated hyperfractionated radiation therapy with carmustine for adults with supratentorial malignant gliomasCancer199677153515438608540
   PubMedGoogle Scholar
• SchwarzSBThonNNikolajekKIodine-125 brachytherapy for brain tumours: a reviewRadiat Oncol201273022394548
   PubMedGoogle Scholar
• ThornCFOshiroCMarshSDoxorubicin pathways: pharmacodynamics and adverse effectsPharmacogenet Genomics20112144044621048526
   PubMed Web of Science ®Google Scholar
• YaqubFMechanism of action of anthracycline drugsLancet Oncol201314e296
   Google Scholar
• Della LattaVCecchettiniADel RySMoralesMABleomycin in the setting of lung fibrosis induction: from biological mechanisms to counteractionsPharmacol Res20159712213025959210
   PubMed Web of Science ®Google Scholar
• von HolstHKnochenhauerEBlomgrenHUptake of adriamycin in tumour and surrounding brain tissue in patients with malignant gliomasActa Neurochir (Wien)199010413162386084
   PubMed Web of Science ®Google Scholar
• HervéFGhineaNScherrmannJMCNS delivery via adsorptive transcytosisAAPS J20081045547218726697
   PubMed Web of Science ®Google Scholar
• ZhanCLuWThe blood-brain/tumor barriers: challenges and chances for malignant gliomas targeted drug deliveryCurr Pharm Biotechnol2012132380238723016643
   PubMed Web of Science ®Google Scholar
• KooYEReddyGRBhojaniMBrain cancer diagnosis and therapy with nanoplatformsAdv Drug Deliv Rev2006581556157717107738
   PubMed Web of Science ®Google Scholar